Press Release

Qkine is excited to be shortlisted for the Business Weekly Awards 2023 alongside scaling and inspirational companies in the Cambridge cluster.

Qkine partners with the UK’s new £12M cellular agriculture manufacturing hub, CARMA, to revolutionize sustainable food production

Qkine is delighted to extended its global reach by agreeing a new sales distribution agreement with Biogenuix, an Indian distribution partner.

Qkine is delighted to announce its collaboration with Sartorius, a global life science group, to supply growth factors and cytokines for stem cell and organoid research, as part of a comprehensive workflow solution.

On Friday, 28th April 2023, Qkine officially opened its new HQ at Murdoch House, Cambridge, UK. We were delighted to be joined by Mayor Dr. Nik Johnson, the Mayor of Cambridge & Peterborough, alongside our team, customers, investors, and representatives from the Cambridge ecosystem.

Qkine is excited to be a Top21.2023 winner in this year’s Cofinitive #21toWatch awards.

Qkine Ltd, a manufacturer of animal-free, highly bioactive, and innovative proteins and growth factors for life science applications, announces the close of its oversubscribed funding raise, having secured £4.3M.

A collaboration between Qkine and 3D Bio-Tissues has been awarded one of four prestigious prizes at the 2022 EIT Food Venture Summit, held in Lisbon, Portugal. Prize money will be used to develop new solutions to reduce the cost of cultivated meat.

Qkine secure a new lease on premises based in Cambridge city centre. The building will be transformed into modern agile lab and office spaces for research and process development, plus a dedicated, beta lactam free state of the art manufacturing suite.

Despite the ongoing challenges faced by the whole industry, we are demonstrating our commitment to supporting stem cell researchers by freezing our prices until January 1st, 2023. Furthermore, we will include free shipping on all orders moving forward.

Qkine certified ISO9001: 2015 for its quality management system encompassing R&D, manufacturing, and operations in Cambridge, UK. Qkine supplies growth factors and cytokines to the fast-moving stem cell, organoid and emerging cultured meat sectors. Exceptional product quality and scientific support are crucial to customer's business processes and experimental outcomes.

Qkine and Enantis have concluded a global licensing deal for Enantis’s patented FGF2-STAB® technology. FGF2-STAB® is a hyperstable form of FGF-2 (bFGF), a core reagent for stem cell culture. FGF2-STAB (FGF2-G3) does not degrade in culture media for enhanced weekend-free stem cell culture media and advanced chemically defined systems, such as those needed in the cultured meat industry.